Creative Biolabs-Immuno-oncology

Anti-CLDN3 (clone CDN2E8P) SynExpress la-Cy3-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR852)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CLDN3 (clone CDN2E8P). We employs the Adenovirus (lac-Cy3-c-Jun-KpnI) vector components and the SynExpress system of the Exons Prime Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CLDN3
Clone
CDN2E8P
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
lac
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Prime Editing
Modification Domain
Exons
Carrier Type
Adenovirus
Transformation Accuracy
0.98
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving